The Efficacy of Aflibercept in the Management of Treatment-Resistant Diabetic Macular Oedema

被引:0
|
作者
Bahrami, Bobak [1 ]
Ewe, Shaun [1 ]
Hong, Thomas [1 ]
Zhu, Meidong [1 ,2 ]
Peto, Tunde [3 ]
Levente, Toth [3 ]
Wong, James [1 ,2 ]
Chang, Andrew [1 ,2 ]
机构
[1] Sydney Inst Vis Sci, Sydney, NSW, Australia
[2] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia
[3] Moorfields Eye Hosp, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1
引用
收藏
页码:24 / 24
页数:1
相关论文
共 50 条
  • [41] Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema
    Ashraf, Mohammed
    El Kayal, Hassan
    Souka, Ahmed A. R.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (05): : 399 - 405
  • [42] The efficacy and safety of aflibercept and conbercept in diabetic macular edema
    Cai, Siwei
    Yang, Qianhui
    Li, Xiaorong
    Zhang, Yan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3471 - 3483
  • [43] COST-EFFECTIVENESS ANALYSIS OF INTRAVITREAL AFLIBERCEPT IN DIABETIC MACULAR OEDEMA IN SWEDEN
    Branco, Castelo A.
    Eriksson, M.
    Nilsson, J.
    VALUE IN HEALTH, 2015, 18 (07) : A420 - A420
  • [44] Aflibercept for diabetic macular oedema (DMO): How effective with foveal intraretinal cysts?
    Radia, Meera
    Dinah, Christiana
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [45] AFLIBERCEPT FOR DIABETIC MACULAR OEDEMA: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Nguyen, Chu Luan
    Lindsay, Andrew
    Wong, Eugene
    Chilov, Michael
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 : 129 - 130
  • [46] Aflibercept for diabetic macular oedema: a Meta-analysis of randomized controlled trials
    Chu Luan Nguyen
    Lindsay, Andrew
    Wong, Eugene
    Chilov, Michael
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (06) : 1002 - 1008
  • [47] Aflibercept for diabetic macular oedema: a Meta-analysis of randomized controlled trials
    Chu Luan Nguyen
    Andrew Lindsay
    Eugene Wong
    Michael Chilov
    International Journal of Ophthalmology, 2018, (06) : 1002 - 1008
  • [48] Comparative effect of intravitreal faricimab versus aflibercept in a patient with diabetic macular oedema
    Montero-Moreno, Javier
    Diez-Montero, Cecilia
    Sanchis-Merino, Maria Eugenia
    Hernandez-Fernandez, Rosario
    Canibano-Perez, Elisabeth
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [49] EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANT TREATMENT IN DIABETIC MACULAR EDEMA REFRACTORY TO INTRAVITREAL AFLIBERCEPT TREATMENT
    Celik, E.
    Sever, O.
    Cakir, B.
    Dogan, E.
    Ozmen, S.
    Atum, M.
    Aksoy, N.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP29 - NP29
  • [50] COST-EFFECTIVENESS OF RANIBIZUMAB VERSUS AFLIBERCEPT IN TREATMENT OF TREATMENT OF VISUAL IMPAIRMENT DUE TO DIABETIC MACULAR OEDEMA (DMO)
    Haig, J.
    Regnier, S. A.
    Malcom, W.
    Xue, W.
    VALUE IN HEALTH, 2014, 17 (07) : A609 - A609